tirzepatide to lose weight Weight-loss drug tirzepatide may lower

While state Medicaid programs must cover nearly all Food and Drug Administration (FDA) approved drugs, a long-standing statutory exception allows states to choose whether to cover weight-loss drugs under Medicaid

however, in the case of injury or disease, loss of NMNAT activity leads to NAD + depletion and NMN accumulation, which in turn activates SARM1 53,54,289

Contact your provider to explore whether a medication adjustment or genetic testing through the Precision Peptide test could optimize your therapy

Tirzepatide is administered as a subcutaneous injection, meaning it goes into the fatty tissue just under the skin, rather than into a muscle or vein